These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Introduction to thematic minireview series: Development of human therapeutics based on induced pluripotent stem cell (iPSC) technology. Rao M; Gottesfeld JM J Biol Chem; 2014 Feb; 289(8):4553-4. PubMed ID: 24362035 [TBL] [Abstract][Full Text] [Related]
3. Future prospects for regenerated heart using induced pluripotent stem cells. Fujita J; Fukuda K J Pharmacol Sci; 2014; 125(1):1-5. PubMed ID: 24739283 [TBL] [Abstract][Full Text] [Related]
4. Steps toward safe cell therapy using induced pluripotent stem cells. Okano H; Nakamura M; Yoshida K; Okada Y; Tsuji O; Nori S; Ikeda E; Yamanaka S; Miura K Circ Res; 2013 Feb; 112(3):523-33. PubMed ID: 23371901 [TBL] [Abstract][Full Text] [Related]
5. Induced Pluripotent Stem Cells for Cardiovascular Disease Modeling and Precision Medicine: A Scientific Statement From the American Heart Association. Musunuru K; Sheikh F; Gupta RM; Houser SR; Maher KO; Milan DJ; Terzic A; Wu JC; Circ Genom Precis Med; 2018 Jan; 11(1):e000043. PubMed ID: 29874173 [TBL] [Abstract][Full Text] [Related]
6. Potential applications of induced pluripotent stem cells (iPSCs) in hepatology research. Sun C; Wilson GS; Fan JG; Qiao L Curr Stem Cell Res Ther; 2015; 10(3):208-15. PubMed ID: 25599714 [TBL] [Abstract][Full Text] [Related]
7. Large Animal Models for the Clinical Application of Human Induced Pluripotent Stem Cells. Cong X; Zhang SM; Ellis MW; Luo J Stem Cells Dev; 2019 Oct; 28(19):1288-1298. PubMed ID: 31359827 [TBL] [Abstract][Full Text] [Related]
8. Recent technological updates and clinical applications of induced pluripotent stem cells. Diecke S; Jung SM; Lee J; Ju JH Korean J Intern Med; 2014 Sep; 29(5):547-57. PubMed ID: 25228828 [TBL] [Abstract][Full Text] [Related]
10. Genomic Instability of iPSCs: Challenges Towards Their Clinical Applications. Yoshihara M; Hayashizaki Y; Murakawa Y Stem Cell Rev Rep; 2017 Feb; 13(1):7-16. PubMed ID: 27592701 [TBL] [Abstract][Full Text] [Related]
11. Efficient Cardiac Differentiation of Human Amniotic Fluid-Derived Stem Cells into Induced Pluripotent Stem Cells and Their Potential Immune Privilege. Fang YH; Wang SPH; Gao ZH; Wu SN; Chang HY; Yang PJ; Liu PY; Liu YW Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32235313 [TBL] [Abstract][Full Text] [Related]
12. Tumorigenicity studies of induced pluripotent stem cell (iPSC)-derived retinal pigment epithelium (RPE) for the treatment of age-related macular degeneration. Kanemura H; Go MJ; Shikamura M; Nishishita N; Sakai N; Kamao H; Mandai M; Morinaga C; Takahashi M; Kawamata S PLoS One; 2014; 9(1):e85336. PubMed ID: 24454843 [TBL] [Abstract][Full Text] [Related]
13. Reverse engineering human neurodegenerative disease using pluripotent stem cell technology. Liu Y; Deng W Brain Res; 2016 May; 1638(Pt A):30-41. PubMed ID: 26423934 [TBL] [Abstract][Full Text] [Related]
14. Human-induced pluripotent stem cells produced under xeno-free conditions. Ross PJ; Suhr ST; Rodriguez RM; Chang EA; Wang K; Siripattarapravat K; Ko T; Cibelli JB Stem Cells Dev; 2010 Aug; 19(8):1221-9. PubMed ID: 20030562 [TBL] [Abstract][Full Text] [Related]
15. Applications of induced pluripotent stem cell technologies in spinal cord injury. Nagoshi N; Okano H J Neurochem; 2017 Jun; 141(6):848-860. PubMed ID: 28199003 [TBL] [Abstract][Full Text] [Related]
16. Pathological classification of human iPSC-derived neural stem/progenitor cells towards safety assessment of transplantation therapy for CNS diseases. Sugai K; Fukuzawa R; Shofuda T; Fukusumi H; Kawabata S; Nishiyama Y; Higuchi Y; Kawai K; Isoda M; Kanematsu D; Hashimoto-Tamaoki T; Kohyama J; Iwanami A; Suemizu H; Ikeda E; Matsumoto M; Kanemura Y; Nakamura M; Okano H Mol Brain; 2016 Sep; 9(1):85. PubMed ID: 27642008 [TBL] [Abstract][Full Text] [Related]
17. Present and future challenges of induced pluripotent stem cells. Ohnuki M; Takahashi K Philos Trans R Soc Lond B Biol Sci; 2015 Oct; 370(1680):20140367. PubMed ID: 26416678 [TBL] [Abstract][Full Text] [Related]
18. Preclinical Safety Evaluation of Allogeneic Induced Pluripotent Stem Cell-Based Therapy in a Swine Model of Myocardial Infarction. Gálvez-Montón C; Soler-Botija C; Iborra-Egea O; Díaz-Güemes I; Martí M; Iglesias-García O; Prat-Vidal C; Crisóstomo V; Llucià-Valldeperas A; Perea-Gil I; Roura S; Sánchez-Margallo FM; Raya Á; Bayes-Genis A Tissue Eng Part C Methods; 2017 Nov; 23(11):736-744. PubMed ID: 28699384 [TBL] [Abstract][Full Text] [Related]
19. Development of histocompatible primate-induced pluripotent stem cells for neural transplantation. Deleidi M; Hargus G; Hallett P; Osborn T; Isacson O Stem Cells; 2011 Jul; 29(7):1052-63. PubMed ID: 21608081 [TBL] [Abstract][Full Text] [Related]
20. iPSCs, aging and age-related diseases. Isobe K; Cheng Z; Nishio N; Suganya T; Tanaka Y; Ito S N Biotechnol; 2014 Sep; 31(5):411-21. PubMed ID: 24784583 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]